Gene Therapy Services

ProBio is a full-service, end-to-end CDMO for gene therapy, with strong capabilities in plasmid and Adeno-associated virus (AAV) development and manufacturing. Our fast, integrated, globally compliant platforms with proprietary technologies, reduce complexity and enable faster progression to clinic. Our rapid 6-8 week time line from plasmid to AAV clinical material, is supported by our triple transfection system and proprietary PowerS™-293 cell line. These drive platform efficiency and consistency, supporting seamless scalable, high quality and reliable AAV manufacturing. Performance efficiency is supported by high titers for lower recombination and improved output. Our globally compliant platforms and facilities have quality built in from the start, de‑risking development and driving cost efficiency through our processes. Over 90 IND clearances globally Over 60 ongoing P&V CMC projects for IND filing Over 700 clinical plasmid batches delivered Over 200 clinical viral vector manufacturing batches delivered Experience in supporting EUA and BLA